Login / Signup

Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis.

Yuqing ZhangXiaoxin ZhangLifan LinMingzhao Xing
Published in: The Journal of clinical endocrinology and metabolism (2024)
The currently used targeted drug therapies for RR-DTC can significantly improve clinical outcomes and the new drug apatinib demonstrates promise for potentially superior performance.
Keyphrases
  • adverse drug
  • big data
  • emergency department
  • drug delivery
  • artificial intelligence